Clinical Updates & Insights

Share
Print

Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

228 Clinical Updates found

Clinical Update

Breast Conservation Therapy Doesn't Compromise Outcomes in Younger Breast Cancer Patients

Breast conservation therapy as an initial treatment did not compromise survival outcomes compared to mastectomy in breast cancer patients under the age of 35.

  • Thursday, January 14, 2021

Clinical Update

MSK Kids: Early Immune Cell Reconstitution Predicted Improved Survival Outcomes in Patients with Graft-versus-Host Disease

Early CD4+ T cell reconstitution predicted non-relapsing mortality and overall survival in pediatric patients who received an allogeneic hematopoietic stem cell transplant (HCT) and developed acute graft-versus-host disease.

  • Thursday, January 14, 2021

Clinical Update

MSK Kids: Retinoblastoma with Choroidal Invasion Successfully Managed with Ophthalmic Artery Chemosurgery, Avoiding Enucleation

Patients with choroidal invasion of retinoblastoma can be successfully managed with ophthalmic artery chemosurgery (OAC) and avoid enucleation.

  • Thursday, January 14, 2021

Clinical Update

Overall Survival After Surgery for Spinal Metastases Has Improved Over the Last Two Decades

Postoperative survival after surgery for spinal metastases has improved over the past 20 years, particularly in patients with kidney, breast, lung, and colon tumors metastatic to the spine.

  • Monday, December 14, 2020

Clinical Update

Patients Undergoing Immunosuppressive Cancer Therapy Can Shed Viable Covid-19 Virus For at Least Two Months

Patients with profound immunosuppression after undergoing hematopoietic stem-cell transplantation or receiving chimeric antigen receptor (CAR) T cell therapy may shed viable SARS-CoV-2 for at least two months.

  • Monday, December 14, 2020

Clinical Update

What is the Optimal Number of Neoadjuvant Chemotherapy Cycles for Newly Diagnosed Ovarian Cancer? - MSK Team Ovary

Receiving five or more cycles of neoadjuvant chemotherapy was associated with worse progression-free survival (PFS) and overall survival (OS) compared to receiving three or four cycles — despite maximal surgical cytoreduction.

  • Friday, November 13, 2020

Clinical Update

Everolimus Plus Bevacizumab Effective for First-Line Treatment of Advanced Papillary Variant Renal Cell Carcinoma

Everolimus plus bevacizumab demonstrates robust activity in treatment-naïve patients with advanced papillary variant nonclear cell renal cell carcinoma.

  • Monday, November 9, 2020

Clinical Update

Total Gastrectomy Indicated for Patients with Stomach Cancer Gene Mutations Regardless of Family History

Total gastrectomy is indicated for patients with stomach cancer gene mutations regardless of family history.

  • Monday, November 9, 2020

Clinical Update

Case Study Illustrates Need for More Effective Treatment Options for Aggressive Pituitary Adenomas

Pituitary adenomas continue to grow in a small subset of patients despite treatment with standard surgery and radiotherapy. Recognizing the significant unmet needs in this cohort, we recently published a review of the latest treatment options.

  • Wednesday, October 14, 2020

Clinical Update

Review: Benefits and Future Directions for Proton Therapy in Head and Neck Cancer

Our review summarizes recent developments in treatment planning and delivery, existing clinical evidence, and ongoing prospective trials in major head and neck cancers that may further increase the therapeutic window of proton therapy for patients with head and neck cancer.

  • Tuesday, October 13, 2020